Shin-Young Park

Shin-Young Park

Auto-generated profile, based on publicly available information

Shin-Young Park

Joint Program in Transfusion Medicine, Department of Pathology, Harvard Medical School; Division of Blood Bank, Department of Laboratory Medicine, Stem Cell Program, Boston Children’s Hospital; and Dana-Farber/Harvard Cancer Center, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
XXXuemei Xie
Xuemei Xie
QSQiang Shi
Qiang Shi
PWPeng Wu
Peng Wu
XZXiaoyu Zhang
Xiaoyu Zhang
HKHiroto Kambara
Hiroto Kambara
HLHongbo R. Luo
Hongbo R. Luo

9 January 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MMMariya Mollova
Mariya Mollova
KBKevin Bersell
Kevin Bersell
SWStuart Walsh
Stuart Walsh
JSJainy Savla
Jainy Savla
LDLala Tanmoy Das
Lala Tanmoy Das
BKBernhard Kühn
Bernhard Kühn
The human heart is believed to grow by enlargement but not proliferation of cardiomyocytes (heart muscle cells) during postnatal development. However, recent studies have shown that cardiomyocyte proliferation is a mechanism of cardiac growth and regeneration in animals. Combined with evidence for cardiomyocyte turnover in adult humans, this suggests that cardiomyocyte proliferation may play an unrecognized role during the period of developmental heart growth between birth and adolescence. We tested this hypothesis by examining the cellular growth mechanisms of the left ventricle on a set of healthy hearts from humans aged 0–59 y ( n = 36). The percentages of cardiomyocytes in mitosis and cytokinesis were highest in infants, decreasing to low levels by 20 y. Although cardiomyocyte mitosis was detectable throughout life, cardiomyocyte cytokinesis was not evident after 20 y. Between the first year and 20 y of life, the number of cardiomyocytes in the left ventricle increased 3.4-fold, which was consistent with our predictions based on measured cardiomyocyte cell cycle activity. Our findings show that cardiomyocyte proliferation contributes to developmental heart growth in young humans. This suggests that children and adolescents may be able to regenerate myocardium, that abnormal cardiomyocyte proliferation may be involved in myocardial diseases that affect this population, and that these diseases might be treatable through stimulation of cardiomyocyte proliferation.

28 April 2013 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
CNCésar Nombela-Arrieta
César Nombela-Arrieta
GPGregory Pivarnik
Gregory Pivarnik
BWBeatrice Winkel
Beatrice Winkel
KCKimberly J. Canty
Kimberly J. Canty
BHBrendan Harley
Brendan Harley
LSLeslie E. Silberstein
Leslie E. Silberstein

1 March 2000 in Cellular Signalling
Verified
Journal Article
Closed access
HAHava Avraham
Hava Avraham
SPShin-Young Park
Shin-Young Park
KSKarin Schinkmann
Karin Schinkmann
SAShalom Avraham
Shalom Avraham

1 August 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SPShin-Young Park
Shin-Young Park
HAHava Karsenty Avraham
Hava Karsenty Avraham
SAShalom Avraham
Shalom Avraham
The related adhesion focal tyrosine kinase (RAFTK), also known as Pyk2, undergoes autophosphorylation upon its stimulation. This leads to cascades of intracellular signaling that result in the regulation of various cellular activities. However, the molecular mechanism of RAFTK autophosphorylation is not yet known. Using various RAFTK constructs fused with two different tags, we found that the autophosphorylation of RAFTK was mediated by a trans-acting mechanism, not a cis-acting mechanism. In addition, overexpression of kinase-mutated RAFTK inhibited wild type RAFTK autophosphorylation in a dose-dependent manner by a trans-acting interaction. Trans-acting autophosphorylation was also observed between endogenous and exogenous RAFTK upon potassium depolarization of neuroendocrine PC12 cells. Using immunoprecipitation and affinity chromatography, we detected RAFTK self-association that was not affected by deletion of a single region or domain of RAFTK. Furthermore, RAFTK autophosphorylation occurred only at site Tyr402 in a Src kinase activity-independent manner. However, Src significantly enhanced RAFTK-mediated paxillin phosphorylation, suggesting a key role for Src in RAFTK activation and phosphorylation of downstream substrates. Our results indicate that the activation of RAFTK occurs in several steps. First, upon stimulus, RAFTK trans-autophosphorylates Tyr402. Second, phosphorylated Tyr402 recruits and activates Src kinase that in turn phosphorylates RAFTK and enhances its kinase activity. Lastly, the enhanced RAFTK activity induces the activation of downstream signaling molecules. Taken together, these studies provide insights into the molecular mechanism of RAFTK autophosphorylation and the specific role of Src in the regulation of RAFTK activation.

21 April 2014 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LKLalit Kumar
Lalit Kumar
JCJanet Chou
Janet Chou
CYChristina S.K. Yee
Christina S.K. Yee
ABArturo Borzutzky
Arturo Borzutzky
EVElisabeth H. Vollmann
Elisabeth H. Vollmann
RGRaif S. Geha
Raif S. Geha
Lrrc8a is a ubiquitously expressed gene that encodes a leucine-rich repeat (LRR)–containing protein detected at higher levels on the surface of thymocytes than on other immune cells. We generated Lrrc8a−/− mice to investigate the role of LRRC8A in lymphocyte development and function. Lrrc8a−/− mice had increased prenatal and postnatal mortality, growth retardation, and multiple tissue abnormalities. Lrrc8a−/− mice displayed a modest block in B cell development but intact intrinsic B cell function. In contrast, both Lrrc8a−/− mice and Lrrc8a−/−→Rag2−/− bone marrow chimeras exhibited a severe cell-intrinsic block in early thymic development, with decreased proliferation and increased apoptosis of thymocytes, and impaired peripheral T cell function. Thymic epithelial cells expressed an LRRC8A ligand that was critical for double-negative to double-positive thymocyte differentiation and survival in vitro. LRRC8A constitutively associated with the GRB2–GAB2 complex and lymphocyte-specific protein tyrosine kinase (LCK) in thymocytes. LRRC8A ligation activated AKT via the LCK–ZAP–70–GAB2–PI3K pathway, and AKT phosphorylation was markedly reduced in the thymus of Lrrc8a−/− mice. These findings reveal an essential role for LRRC8A in T cell development, survival, and function.